OpenBilldrug price receipt

NADAC week of 2026-10-14

QUETIAPINE FUMARATE 50 MG TAB

For 30 tablets

Pharmacies pay

$0.85 filed

30 × $0.02817 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$9.44 filed

30 × $0.31465 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

11.2× estimated

Medicare paid 11.2× what pharmacies pay.

Part D averages every strength and form sold under “Quetiapine Fumarate” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$5.98 estimated

$0.85 + $0.13 (15%) + $5.00 fee per fill = $5.98

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

QUETIAPINE FUMARATE 50 MG TAB is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “quetiapine” and “quetiapine fumarate”, as its NDCs’ listings variously write the nonproprietary name.

FDA gives its dosage form as “tablet, film coated” and “tablet” and its route as oral.

FDA lists 15 labelers (the companies named on the label) for its NDCs, among them Teva Pharmaceuticals USA, Inc., Major Pharmaceuticals and Rising Pharma Holdings, Inc.

FDA’s Established Pharmacologic Class for it is Atypical Antipsychotic.

The NADAC file of 2026-10-14 prices it under 24 NDCs (National Drug Codes); the FDA directory lists 22 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $0.85 for 30 tablets (30 × $0.02817 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 15 labelers

LabelerNDCsPharmacies pay per unit
Ascend Laboratories, LLC2$0.02817 per EA filed
BluePoint Laboratories2$0.02817 per EA filed
Lupin Pharmaceuticals, Inc.2$0.02817 per EA filed
NorthStar Rx LLC2$0.02817 per EA filed
Rising Pharma Holdings, Inc.2$0.02817 per EA filed
Solco Healthcare US, LLC2$0.02817 per EA filed
Unichem Pharmaceuticals (USA), Inc.2$0.02817 per EA filed
American Health Packaging1$0.02817 per EA filed
Aurobindo Pharma Limited1$0.02817 per EA filed
AvPAK1$0.02817 per EA filed
Camber Pharmaceuticals, Inc.1$0.02817 per EA filed
Major Pharmaceuticals1$0.02817 per EA filed
Quallent Pharmaceuticals Health LLC1$0.02817 per EA filed
Sun Pharmaceutical Industries, Inc.1$0.02817 per EA filed
Teva Pharmaceuticals USA, Inc.1$0.02817 per EA filed
Not listed as a package in the FDA directory2$0.02817 per EA filed
All 24 NDCs, with labeler and price
  • 00093-8166-01 · Teva Pharmaceuticals USA, Inc. · $0.02817 per EA · eff. 2026-09-23 filed
  • 00904-6639-61 · Major Pharmaceuticals · $0.02817 per EA · eff. 2026-09-23 filed
  • 16571-0718-01 · Rising Pharma Holdings, Inc. · $0.02817 per EA · eff. 2026-09-23 filed
  • 16571-0718-10 · Rising Pharma Holdings, Inc. · $0.02817 per EA · eff. 2026-09-23 filed
  • 16714-0376-01 · NorthStar Rx LLC · $0.02817 per EA · eff. 2026-09-23 filed
  • 16714-0376-02 · NorthStar Rx LLC · $0.02817 per EA · eff. 2026-09-23 filed
  • 29300-0148-01 · Unichem Pharmaceuticals (USA), Inc. · $0.02817 per EA · eff. 2026-09-23 filed
  • 29300-0148-10 · Unichem Pharmaceuticals (USA), Inc. · $0.02817 per EA · eff. 2026-09-23 filed
  • 31722-0765-01 · Camber Pharmaceuticals, Inc. · $0.02817 per EA · eff. 2026-09-23 filed
  • 43547-0519-10 · Solco Healthcare US, LLC · $0.02817 per EA · eff. 2026-09-23 filed
  • 43547-0519-11 · Solco Healthcare US, LLC · $0.02817 per EA · eff. 2026-09-23 filed
  • 47335-0903-88 · Sun Pharmaceutical Industries, Inc. · $0.02817 per EA · eff. 2026-09-23 filed
  • 50268-0631-11 · not listed as a package in the FDA directory · $0.02817 per EA · eff. 2026-09-23 filed
  • 50268-0631-15 · AvPAK · $0.02817 per EA · eff. 2026-09-23 filed
  • 60687-0338-01 · American Health Packaging · $0.02817 per EA · eff. 2026-09-23 filed
  • 60687-0338-11 · not listed as a package in the FDA directory · $0.02817 per EA · eff. 2026-09-23 filed
  • 65862-0490-01 · Aurobindo Pharma Limited · $0.02817 per EA · eff. 2026-09-23 filed
  • 67877-0249-01 · Ascend Laboratories, LLC · $0.02817 per EA · eff. 2026-09-23 filed
  • 67877-0249-10 · Ascend Laboratories, LLC · $0.02817 per EA · eff. 2026-09-23 filed
  • 68001-0180-00 · BluePoint Laboratories · $0.02817 per EA · eff. 2026-09-23 filed
  • 68001-0180-08 · BluePoint Laboratories · $0.02817 per EA · eff. 2026-09-23 filed
  • 68180-0446-01 · Lupin Pharmaceuticals, Inc. · $0.02817 per EA · eff. 2026-09-23 filed
  • 68180-0446-03 · Lupin Pharmaceuticals, Inc. · $0.02817 per EA · eff. 2026-09-23 filed
  • 82009-0096-10 · Quallent Pharmaceuticals Health LLC · $0.02817 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

12 other products in the NADAC file share an FDA nonproprietary name with QUETIAPINE FUMARATE 50 MG TAB.

ProductPharmacies pay per unitMedicare per unit
QUETIAPINE 150 MG TABLET
generic · tablet, film coated
$1.23864 per EA filed
eff. 2026-09-23
$0.31465 per EA filed
Part D 2024 average
QUETIAPINE ER 50 MG TABLET
generic · tablet, film coated, extended release / tablet, extended release
$0.11917 per EA filed
eff. 2026-09-23
$1.3832 per EA filed
Part D 2024 average
QUETIAPINE ER 150 MG TABLET
generic · tablet, film coated, extended release / tablet, extended release
$0.18361 per EA filed
eff. 2026-09-23
$1.3832 per EA filed
Part D 2024 average
QUETIAPINE ER 200 MG TABLET
generic · tablet, film coated, extended release / tablet, extended release
$0.21991 per EA filed
eff. 2026-09-23
$1.3832 per EA filed
Part D 2024 average
QUETIAPINE ER 300 MG TABLET
generic · tablet, film coated, extended release / tablet, extended release
$0.27174 per EA filed
eff. 2026-09-23
$1.3832 per EA filed
Part D 2024 average
QUETIAPINE ER 400 MG TABLET
generic · tablet, film coated, extended release / tablet, extended release
$0.31743 per EA filed
eff. 2026-09-23
$1.3832 per EA filed
Part D 2024 average
QUETIAPINE FUMARATE 25 MG TAB
generic · tablet, film coated / tablet
$0.02147 per EA filed
eff. 2026-09-23
$0.31465 per EA filed
Part D 2024 average
QUETIAPINE FUMARATE 50 MG TAB this page
generic · tablet, film coated / tablet
$0.02817 per EA filed
eff. 2026-09-23
$0.31465 per EA filed
Part D 2024 average
QUETIAPINE FUMARATE 100 MG TAB
generic · tablet, film coated / tablet
$0.0483 per EA filed
eff. 2026-09-23
$0.31465 per EA filed
Part D 2024 average
QUETIAPINE FUMARATE 200 MG TAB
generic · tablet, film coated / tablet
$0.08962 per EA filed
eff. 2026-09-23
$0.31465 per EA filed
Part D 2024 average
QUETIAPINE FUMARATE 300 MG TAB
generic · tablet, film coated / tablet
$0.12747 per EA filed
eff. 2026-09-23
$0.31465 per EA filed
Part D 2024 average
QUETIAPINE FUMARATE 400 MG TAB
generic · tablet, film coated / tablet
$0.16163 per EA filed
eff. 2026-09-23
$0.31465 per EA filed
Part D 2024 average
SEROQUEL XR 400 MG TABLET
brand · tablet, extended release
$26.35797 per EA filed
eff. 2026-09-23
$18.8754 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 24 NDCs’ NADAC prices is $0.02817 per EA filed.

Of the 130 other products in FDA’s Atypical Antipsychotic class priced per EA, 129 have a higher middle NADAC price and 1 a lower one. The one in the middle is CLOZAPINE ODT 100 MG TABLET, at $4.26464 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $9.44 for 30 tablets, at an average of $0.31465 per EA in 2024 (2024-01-01 to 2024-12-31) for “Quetiapine Fumarate”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 9,340,374 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for QUETIAPINE FUMARATE 50 MG TAB labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Quetiapine Fumarate / Quetiapine Fumarate: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.